Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gedatolisib|DRUG: Faslodex|DRUG: Palbociclib|DRUG: Zoladex
Sponsor: Hoffman Oncology
Collaborators: DSCS CRO